Authors:
Borchers, H
Brehmer, B
van Poppel, H
Jakse, G
Citation: H. Borchers et al., Radical prostatectomy in patients with previous groin hernia repair using synthetic nonabsorbable mesh, UROL INTERN, 67(3), 2001, pp. 213-215
Authors:
Borchers, H
Wolff, JM
Brehmer, B
Beniers, AJMC
Jakse, G
Citation: H. Borchers et al., Reverse transcriptase-polymerase chain reaction and immunocytochemistry from bone marrow and peripheral blood for detection of microdisseminated prostate cancer. A comparative analysis, UROLOGE A, 39(6), 2000, pp. 565-571
Authors:
Wolff, JM
Boekels, O
Borchers, H
Jakse, G
Rohde, D
Citation: Jm. Wolff et al., Altered prostate specific antigen reference range after transurethral resection of the prostate, ANTICANC R, 20(6D), 2000, pp. 4977-4980
Authors:
Wolff, JM
Brehmer, B
Borchers, H
Rohde, D
Jakse, G
Citation: Jm. Wolff et al., Are age-specific reference ranges for prostate specific antigen populationspecific?, ANTICANC R, 20(6D), 2000, pp. 4981-4983
Citation: Jm. Wolff et al., Tissue polypeptide specific antigen serum concentrations in patients with newly diagnosed prostatic diseases, ANTICANC R, 20(6D), 2000, pp. 5003-5005
Authors:
Wolff, JM
Ittel, TH
Borchers, H
Boekels, O
Jakse, G
Citation: Jm. Wolff et al., Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase, ANTICANC R, 19(4A), 1999, pp. 2653-2655
Authors:
Wolff, JM
Fandel, TH
Borchers, H
Jakse, G
Citation: Jm. Wolff et al., Serum concentrations of transforming growth factor-beta 1 in patients withbenign and malignant prostatic diseases, ANTICANC R, 19(4A), 1999, pp. 2657-2659
Authors:
Cremerius, U
Wildberger, JE
Borchers, H
Zimny, M
Jakse, G
Gunther, RW
Buell, U
Citation: U. Cremerius et al., Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer? - Results of a study in 50 patients, UROLOGY, 54(5), 1999, pp. 900-904
Authors:
Meyers, FJ
Gumerlock, PH
Chi, SG
Borchers, H
Deitch, AD
White, RWD
Citation: Fj. Meyers et al., Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors, CANCER, 83(12), 1998, pp. 2534-2539